Accelerate optimization with media and feed evaluations

Identifying the right nutrient composition for a specific clone or process is one of the more demanding stages of upstream process (USP) development. Gibco Media by Design Services support this step through high-throughput media screening (HTMS) and media and feed panel evaluations.

HTMS enables concurrent evaluation of Gibco media, feeds, and prototype formulations at the micro-scale, generating comparative performance data to guide early media selection. Gibco media and feed panels offer ready-to-use formulations designed to explore nutrient space beyond catalog media.

Screening options support applications including Chinese hamster ovary (CHO), suspension HEK293, adherent kidney cells, and monoclonal antibody (mAb) galactosylation.

Evaluate formulations with high-throughput media screening


High-throughput media screening (HTMS) enables rapid evaluation of Gibco catalog media, feeds, and prototype formulations at the micro-scale. Testing multiple conditions simultaneously generates comparative performance data to guide early media selection. Up to 180 Gibco media and feed combinations, including both catalog and prototype formulations, are evaluated in automated high-throughput deep-well (DW) plate formats.

 

Results are reviewed together, typically within a 12-week timeframe, to support the selection of a lead formulation.

Go beyond catalog testing with screening panels

Catalog products usually offer limited formulation information, making it difficult to conduct a diverse evaluation. Cell culture media panels are designed with nutritional diversity across amino acids, vitamins, lipids, trace metals, amines, nucleosides, and organic acids, enabling teams to identify nutrient drivers of productivity and quality more quickly.

Gibco GlycanMod Panel


The Gibco GlycanMod Panel is designed to optimize monoclonal antibody (mAb) galactosylation, a critical quality attribute affecting therapeutic efficacy. Chemically defined formulations work across various cell lines and media to fine-tune N-glycan profiles. Titratable, ready-to-use solutions can enable rapid modification of galactosylation without compromising cell growth or productivity. The panel is designed to support batch-to-batch consistency throughout the process lifecycle.

Gibco CHO Media and Feed Panel

The Gibco CHO Media and Feed Panel consists of nine chemically defined (CD), animal origin-free (AOF) media formulations and five feed formulations, each with distinct nutrient compositions. In microbioreactor testing across two CHO cell lines (CHO-K1 and CHO-S lineages), the media panel demonstrated a 2.0-fold titer increase over control for Cell Line A and a 4.2-fold increase for Cell Line B.1 Following evaluation, a field application scientist (FAS) reviews growth, metabolite, titer, and product quality data and recommends next steps.

Gibco Adherent Kidney Media Panel


The Gibco Adherent Kidney Media Panel is formulated for viral vaccine production using adherent kidney cell lines. The panel is designed to support the rapid identification of serum-free formulations that enable both cell growth and productivity.

Gibco Viral Vector HEK Media and Feed Panel

Designed to accelerate gene therapy development and production using suspension HEK293 cells, the Gibco Viral Vector HEK Media and Feed Panel covers a wide range of HEK293 suspension cell lines. The panel is not tied to specific transfection reagents or techniques, giving process developers flexibility across workflows. Ready-to-use formulations are designed to help identify an optimal formulation for a target cell line.

Unsure which panel is right for you?

From panel results to custom media development


Following the evaluation, an FAS consultation reviews growth, metabolite, titer, and product quality data to guide the next steps. These may include a spent media analysis to characterize nutrient utilization, multi-omics profiling to identify productivity-driving pathways, rapid prototyping to assess manufacturability, or progression to cGMP manufacturing.

Frequently asked questions

High-throughput media screening is a micro-scale approach used to evaluate multiple cell culture media and feed formulations concurrently. By comparing many conditions simultaneously, HTMS generates growth and productivity data that helps guide early media selection during upstream process development. It is often used when teams need to assess several candidate formulations quickly before advancing promising conditions into targeted optimization or broader media development workflows. Results are reviewed together, typically within a 12-week timeframe, to support the selection of a lead formulation.

A panel evaluation offers access to a library of ready-to-use formulations with distinct nutrient profiles across amino acids, vitamins, lipids, trace metals, amines, nucleosides, and organic acids. Catalog screening typically offers limited formulation information, making it difficult to conduct a truly diverse evaluation. Panels are designed to maximize formulation diversity, helping identify the nutrients driving productivity more quickly.

The CHO Media and Feed Panel is designed for CHO-based mAb and recombinant protein processes. The Viral Vector HEK Media and Feed Panel targets suspension HEK293 cells for gene therapy applications. The Adherent Kidney Media Panel addresses viral vaccine production using adherent kidney cell lines. The GlycanMod Panel is designed for mAb galactosylation optimization. For further guidance, consult our specialists.

Each panel evaluation includes a study plan and an experimental protocol to structure the screening process, along with technical support throughout the process. The evaluation begins with a kickoff meeting with an FAS, who offers guidance on the protocol based on goals, clone needs, and available equipment. Upon completion, the FAS reviews data on growth, metabolites, titer, and product quality and recommends the next steps.

Panel evaluation results can inform a range of next steps. Spent media analysis or multi-omics profiling can identify opportunities for formulation refinement. When results indicate further optimization is needed, Gibco Media Development Services offers DoE-based and multi-omics-guided workflows. Formulations ready for scale-up can progress to Gibco Rapid Prototyping Services or cGMP manufacturing for manufacturability assessment.

A media and feed screening is one step in a broader upstream development journey. Gibco Media by Design Services support progression from screening through custom formulation development, scale-up, and commercial manufacturing.

Media development

Align formulations with specific cell lines and process requirements as programs mature. Using established experimental workflows, formulations can be tailored to support productivity, growth performance, product quality, and manufacturability during scale-up and process optimization.

Bioprocess analytics

Link media composition to cell behavior and product attributes with bioprocess analytics. These insights help clarify nutrient utilization and metabolic responses, enabling data-driven adjustments to media formulations as processes evolve.
 

For research use or further manufacturing. Not for diagnostic use or direct administration into humans or animals.